ESMO 2022 Conference Coverage
A

ESMO 2022 on the Global Phase 3 Multiregional Clinical Trial FRESCO-2: Evaluating the Efficacy & Safety of Fruquintinib in Refractory mCRC

By ESMO 2022 Conference Coverage FEATURING Arvind Dasari
By ESMO 2022 Conference Coverage FEATURING Arvind Dasari
254 views
September 30, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

21:24
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss

Featured Video

13:36
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Feat. J. Gutierrez, J. Strauss

Related Videos

18:21

GI Cancers: Hot Topics in 2024

Yale Cancer Center

J. Lacy

470 views
14:19

ESMO 2024 Summary: Late-Line Therapy in mCRC - How to Choose

2024 ESMO Annual Meeting Insights Hub

H. Hochster

433 views
04:40

ESMO 2024 Summary: Neoadjuvant Colon Cancer Treatment - Recent Clini…

2024 ESMO Annual Meeting Insights Hub

J. Taieb

311 views
03:08

The Importance of 1L Biomarkers in CRC

Nicholas DeVito

720 views
14:02

ESMO 2024 Summary: Highlights in CRC and Impacts on Practice

2024 ESMO Annual Meeting Insights Hub

R. Kim, T. Biachi

211 views
20:07

ESMO 2024 Summary: Developmental Therapeutics Highlights

2024 ESMO Annual Meeting Insights Hub

G. Sonpavde

261 views
24:57

ASCO® 2024 Summary: "CRC Key Studies Including TRANSMET, CheckMate 8…

2024 ASCO® Annual Meeting Insights Hub

R. Kim, T. Biachi

560 views
16:57

ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NS…

2024 ASCO® Annual Meeting Insights Hub

V. Subbiah

680 views
15:31

Clinical Implications of Tumor Agnostic Therapies

Shivaani Kummar

308 views
55:10

History of Cancer and Its Treatment: What Will It Take to Cure?

University of Colorado Cancer Center

C. Lieu

326 views
15:45

ASCO® 2024 Summary: "Experts Discuss Key Updates in Colorectal Cance…

2024 ASCO® Annual Meeting Insights Hub

S. Chakrabarti, A. Shreenivas

392 views
09:23

ESMO 2024 Insights: The Value of Immune Checkpoint Blockade in MSS/p…

2024 ESMO Annual Meeting Insights Hub

B. Geisler

133 views
22:27

Developmental Therapeutics Highlights From ASCO® 2024

2024 ASCO® Annual Meeting Insights Hub

G. Sonpavde

535 views
09:25

ASCO® 2024 Summary: "Expert Panel Discussion on CRC Including TRANSM…

2024 ASCO® Annual Meeting Insights Hub

N. Uboha, K. Spencer, M. Cecchini

354 views
13:29

Treating KRAS-Mutated mCRC

Ibrahim Sahin

697 views
06:20

Anti-EGFR Therapy in CRC: How to Manage Toxicities

Ibrahim Sahin

137 views
15:51

2024 Updates on 1L MSI-H/dMMR mCRC and Using ctDNA MRD Testing in Ea…

Total Health

A. Grothey

488 views
18:26

Guidance on Incorporating Anti-EGFR Therapy in 1L CRC Practice

Ibrahim Sahin

136 views
06:51

ASCO® 2024 Insights: "PanaMa Trial - FU/FA Maintenance Therapy With …

2024 ASCO® Annual Meeting Insights Hub

D. Modest

307 views
12:29

ASCO® 2024 Summary: "Fruquintinib in Refractory mCRC"

2024 ASCO® Annual Meeting Insights Hub

C. Eng

203 views
AUTOPLAY